Location History:
- Witney, GB (2016)
- Oxfordshire, GB (2017)
Company Filing History:
Years Active: 2016-2017
Introduction
Mark Hooper is a notable inventor based in Oxfordshire, GB, recognized for his contributions to the field of pharmaceutical crystallization. With a total of two patents to his name, Hooper has made significant strides in developing innovative solutions for complex compounds.
Latest Patents
Hooper's latest inventions include two distinct types of crystals derived from a specific compound. The first patent, titled "Free Base Crystals," pertains to the formulation of crystals of (6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)-cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one, alongside methods of making and utilizing these crystals. The second patent, "Salt Crystals," focuses on acid addition salt and salt crystals of the same compound, as well as the composition and methods of producing and using these salt and crystal formations.
Career Highlights
Mark Hooper is currently affiliated with Intra-Cellular Therapies, Inc., a company renowned for its commitment to developing innovative therapies for neuropsychiatric diseases. Through his work, Hooper has demonstrated a strong focus on advancing pharmaceutical science by exploring new ways to utilize crystallized forms of complex compounds.
Collaborations
Hooper has collaborated with esteemed colleagues, including Peng Li and Lawrence P. Wennogle. These partnerships have facilitated the exchange of ideas and expertise, enabling the development of effective pharmaceutical solutions.
Conclusion
In conclusion, Mark Hooper's innovative approach to crystallization has paved the way for enhanced methodologies in the pharmaceutical industry. His contributions through patented inventions underscore the importance of research and collaboration in the ongoing quest for effective therapeutic solutions.